US1104481072 - ADR

Taking everything into account, **BTI** scores **4** out of 10 in our fundamental rating. **BTI** was compared to 8 industry peers in the **Tobacco** industry. There are concerns on the financial health of **BTI** while its profitability can be described as average. **BTI** has a bad growth rate and is valued cheaply.

In the past year **BTI** had a positive cash flow from operations.

Each year in the past 5 years **BTI** had a positive operating cash flow.

With a decent **Return On Equity** value of **-25.57%**, **BTI** is doing good in the industry, outperforming **62.50%** of the companies in the same industry.

Measured over the past 3 years, the **Average Return On Invested Capital** for **BTI** is significantly below the industry average of **32.50%**.

The 3 year average ROIC (**7.24%**) for **BTI** is below the current ROIC(**7.93%**), indicating increased profibility in the last year.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -11.59% | ||

ROE | -25.57% | ||

ROIC | 7.93% |

ROA(3y)-0.94%

ROA(5y)1.18%

ROE(3y)-2.78%

ROE(5y)2.16%

ROIC(3y)7.24%

ROIC(5y)6.77%

Looking at the **Gross Margin**, with a value of **82.58%**, **BTI** belongs to the top of the industry, outperforming **100.00%** of the companies in the same industry.

In the last couple of years the **Gross Margin** of **BTI** has remained more or less at the same level.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 41.79% | ||

PM (TTM) | N/A | ||

GM | 82.58% |

OM growth 3Y4.15%

OM growth 5Y3.24%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.75%

GM growth 5Y0.16%

The number of shares outstanding for **BTI** remains at a similar level compared to 1 year ago.

Compared to 5 years ago, **BTI** has less shares outstanding

Based on the Altman-Z score of **1.35**, we must say that **BTI** is in the distress zone and has some risk of bankruptcy.

Looking at the **Altman-Z score**, with a value of **1.35**, **BTI** is doing worse than **75.00%** of the companies in the same industry.

The Debt to FCF ratio of **BTI** is **3.92**, which is a good value as it means it would take **BTI**, **3.92** years of fcf income to pay off all of its debts.

With an excellent **Debt to FCF ratio** value of **3.92**, **BTI** belongs to the best of the industry, outperforming **87.50%** of the companies in the same industry.

A Debt/Equity ratio of **0.61** indicates that **BTI** is somewhat dependend on debt financing.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.61 | ||

Debt/FCF | 3.92 | ||

Altman-Z | 1.35 |

ROIC/WACC1.24

WACC6.38%

A Quick Ratio of **0.58** indicates that **BTI** may have some problems paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 0.88 | ||

Quick Ratio | 0.58 |

The earnings per share for **BTI** have decreased by **-5.77%** in the last year.

Measured over the past 5 years, **BTI** shows a small growth in **Earnings Per Share**. The EPS has been growing by **4.83%** on average per year.

Looking at the last year, **BTI** shows a decrease in **Revenue**. The Revenue has decreased by **-7.24%** in the last year.

Measured over the past years, **BTI** shows a small growth in **Revenue**. The Revenue has been growing by **2.18%** on average per year.

EPS 1Y (TTM)-5.77%

EPS 3Y4.23%

EPS 5Y4.83%

EPS Q2Q%-6.77%

Revenue 1Y (TTM)-7.24%

Revenue growth 3Y1.91%

Revenue growth 5Y2.18%

Sales Q2Q%-8.19%

Based on estimates for the next years, **BTI** will show a small growth in **Earnings Per Share**. The EPS will grow by **4.54%** on average per year.

The **Revenue** is expected to grow by **1.20%** on average over the next years.

EPS Next Y-3.61%

EPS Next 2Y-0.01%

EPS Next 3Y2%

EPS Next 5Y4.54%

Revenue Next Year-5.67%

Revenue Next 2Y-2.26%

Revenue Next 3Y-0.64%

Revenue Next 5Y1.2%

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

Compared to the rest of the industry, the **Price/Earnings** ratio of **BTI** indicates a rather cheap valuation: **BTI** is cheaper than 100.00% of the companies listed in the same industry.

When comparing the **Price/Earnings** ratio of **BTI** to the average of the S&P500 Index (**27.91**), we can say **BTI** is valued rather cheaply.

The **Price/Forward Earnings** ratio is **7.24**, which indicates a rather cheap valuation of **BTI**.

Based on the **Price/Forward Earnings** ratio, **BTI** is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.

Compared to an average S&P500 **Price/Forward Earnings** ratio of **23.57**, **BTI** is valued rather cheaply.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 7.49 | ||

Fwd PE | 7.24 |

100.00% of the companies in the same industry are more expensive than **BTI**, based on the **Price/Free Cash Flow** ratio.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 5.92 | ||

EV/EBITDA | 2.29 |

PEG (NY)N/A

PEG (5Y)1.55

EPS Next 2Y-0.01%

EPS Next 3Y2%

Compared to an average S&P500 **Dividend Yield** of **2.26**, **BTI** pays a better dividend.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 8.74% |

The dividend of **BTI** has a limited annual growth rate of **3.59%**.

The dividend of **BTI** decreased in the last 3 years.

Dividend Growth(5Y)3.59%

Div Incr Years2

Div Non Decr Years2

The earnings of **BTI** are negative and hence is the payout ratio. **BTI** will probably not be able to sustain this dividend level.

DP-37.45%

EPS Next 2Y-0.01%

EPS Next 3Y2%

**BRITISH AMERICAN TOB-SP ADR**

NYSE:BTI (11/6/2024, 3:34:08 PM)

**35.705**

**+0.24 (+0.69%) **

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupFood, Beverage & Tobacco

GICS IndustryTobacco

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap78.84B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 8.74% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 7.49 | ||

Fwd PE | 7.24 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)1.55

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -11.59% | ||

ROE | -25.57% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 41.79% | ||

PM (TTM) | N/A | ||

GM | 82.58% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.22

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.61 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 0.88 | ||

Quick Ratio | 0.58 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)-5.77%

EPS 3Y4.23%

EPS 5Y

EPS Q2Q%

EPS Next Y-3.61%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-7.24%

Revenue growth 3Y1.91%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y